๐ Exciting to see our work @sloankettering on bringing WGS to pediatric cancer patients featured on the @Newsweek cover!
With @carisls & @TempusAI now launching commercial WGS for myeloid leukemias, the future is clear: WGS for every cancer patient is coming. ๐งฌ
A major problem with cell-free tumor DNA to detect cancer (Liquid biopsy) is its very low quantity. Today @NatureMedicine use of #AI to overcome that issue with impressive results for radical signal-to-noise enrichment
https://t.co/zMWaq3F8jP
free access https://t.co/VPLpESbw3a
MRD-EDGE is out today in @NatureMedicine! Thrilled to see this in print when the future for #ctdna in plasma whole genome sequencing is brighter than ever.